Clinical Nutrition - Fatolip

Generic Name: Medium and Long Chain Fat Emulsion Injection (C8~24Ve).

Indications: Provides energy and essential fatty acids for patients requiring parenteral nutrition.

Composition

250ml emulsion for infusion contains:

Soybean Oil	25.0g
Medium Chain Triglyceride	25.0g
Strength	20%
Energy	477kcal/250ml
Excipients	Egg yolk lecithin, glycerol, Vitamin E, Sodium hydroxide, water for injection

Dosage and Administration

Administration Routes: Peripheral or central venous infusion; can be co-administered with glucose and amino acid solutions.

Adult Dosage: 1-2 g lipids/kg body weight/day (equivalent to 5-10 ml/kg/day).

Infants and Pediatric Dosage: Varies by age, with maximum infusion rates based on tolerance.

Key Warnings

Premature Infants: Reports of lipidosis and death; infants have reduced fat elimination ability.

Adverse Reactions: Potential adverse reactions include hyperlipidemia, allergic responses, metabolic acidosis, and fat overload syndrome at higher doses or impaired elimination.

Contraindications

Allergy: To Soy, egg or any composition of this drug.

Severe Conditions: Hyperlipidemia, hepatic or renal failure without replacement therapy, metabolic acidosis, and more.

Storage

Store at not more than 25 ℃. Do not freeze.
Do not use if bag is leak, or contains any foreign matter.

Packaging

Packaging container: 5-layer co-extrusion PE film infusion bag.
Volume: 250ml (common pack size used in clinical large volume infusion.